Monday, August 31, 2026

Aware, Inc. Stock Soars 34% As Investors Rejoice

ViaNews Editorial Team

November 3, 2023

Aware, Inc. Stock Soars 34% As Investors Rejoice

(VIANEWS) - Aware, Inc. (NASDAQ: AWRE) shares surged by 34.25% to EUR1.41 at 22:23 EST on Thursday evening following two consecutive sessions of declines. This marked an important turnaround in Aware's stock performance which had previously been trending downhill. NASDAQ also saw an upward trend, increasing 1.46% to EUR13,251.67 after four consecutive days of gains. This indicates an upward trend in trading today; Aware Inc's last closing price was EUR1.05, 47.76% lower than its 52-week high of EUR2.01. Recent performances for this company have been mixed, with both gains and losses experienced across its stock. However, its recent price increase may signal hope for its future prospects. As a financial news specialist, it's vitally important that one stays abreast of market trends and individual stock performances to remain informed on current events in finance.

About Aware, Inc.

Aware, Inc. is a biometric authentication company offering software solutions and products to government agencies and commercial entities across the US, Brazil, UK and internationally. Their offerings include Knomi (mobile biometric framework), AwareABIS, AFIX Suite AFIX Tracker BioSP WebEnroll AwareID; as well as Nexa Line SDK for biometric search/match and Finger Match SDK respectively. In addition, Aware offers imaging products program management software engineering maintenance services from their base in Burlington Massachusetts since 1986. Aware began operations from 1986 and continues today from Burlington Massachusetts

Yearly Analysis

Based on available data, Aware, Inc.'s stock (AWARE) is currently trading at EUR1.41, significantly below its 52-week high of EUR2.01 but higher than its 52-week low of EUR1.07. Sales growth at Aware, Inc. is projected to see an expected 14.9% surge this year and 16.3% leap next year. However, Aware Inc's EBITDA stands at an alarming negative number -3.76 which could signal that its operations are failing to generate positive cash flow for investors and be cause for worry as this indicates the company may be struggling to turn profits and may not be able to sustain operations over the long haul. As Aware, Inc. currently boasts negative EBITDA and has a relatively low stock price compared to its 52-week high, investors should exercise extreme caution when considering investing in this stock. Wait for positive announcements or financial performance before considering investing.

Technical Analysis

Aware, Inc. stock is currently trading above its 50-day moving average of EUR1.41 while trading below its 200-day moving average of EUR1.60, suggesting a potential short-term downward trend as well as long-term losses for Aware Inc. The stock's volume of 2753802 is significantly greater than its average volume of 21426, suggesting increased trading activity and possible greater liquidity in its shares. Regarding volatility, Aware, Inc. saw its intraday variation average change for the past week, month, and quarter at negative 0.61%; negative 1.41%; and positive 2.45% respectively. Furthermore, its highest amplitude of average volatility reached 2.46% over this timeframe (last week); 2.53% over month; and 2.45% (quarter). Overall, these indicators point toward a potentially volatile stock with a short-term decline trend but potential for greater liquidity and trading activity.

Quarter Analysis

Based on available data, Aware Inc has experienced negative sales growth of 3.3% for this quarter; this should be cause for alarm; however, their projected 52.6% sales increase should offer much needed relief. Revenue growth at the company has experienced a decrease of 24.9% year-on-year over its twelve trailing months, reaching 14.57M currently. This could be caused by various factors, including changes in market demand or competition or internal issues that contribute to this decrease. Overall, investors should carefully follow Aware Inc's performance in the coming quarter to gauge if its anticipated sales growth materializes and identify any factors contributing to any decreases in revenue growth as well as assess whether Aware has taken measures to address such concerns.

Equity Analysis

Based on the available data, Aware Inc is currently not considered an attractive investment opportunity. Their low EPS and ROE indicate they may not be making profits for shareholders; furthermore, its relatively low dividend yield of 2.47% may not provide significant income to investors. Notably, negative EPS and ROE may be temporary factors such as an unexpectedly downturn in business activity, with hopes that performance could improve in future quarters - although without additional information on its financial health, growth prospects, or market conditions it would be difficult to provide more detailed analysis. Before making any investment decisions, investors should carefully evaluate a range of factors, such as financial performance, growth prospects, market conditions and any relevant information.

More news about Aware, Inc. (AWRE).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com